How to Get CagriSema Online in Lithuania
CagriSema is not yet approved in the EU for weight loss. This article explains its current status and, more importantly, guides you to EU-approved, safe, and effective weight-loss treatments readily available through Hi-Doctor's.
DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
Many individuals in Lithuania and across the EU are seeking effective weight-management solutions, and the emerging treatment CagriSema has captured significant attention. However, it's crucial to understand that CagriSema is currently not approved for weight-loss prescription in the EU and is not offered by Hi-Doctor. This innovative peptide is still undergoing clinical trials and is not yet available through legal, regulated channels. This article will explain what CagriSema is, why it's not yet a standard option, and critically, what proven, EU-approved weight-loss treatments you CAN access today from an EU-licensed doctor.
What is CagriSema, and why isn't it a normal option yet?
CagriSema is an investigational drug that combines two active compounds: semaglutide (a GLP-1 receptor agonist) and cagrilintide (an amylin analog). This combination aims to provide a more comprehensive approach to weight loss by targeting multiple pathways involved in appetite regulation and metabolism. While clinical trials show promising results for significant weight reduction, it is still in advanced stages of development. The European Medicines Agency (EMA) has not yet granted marketing authorization for CagriSema, meaning it cannot be legally prescribed or sold in Lithuania or any other EU country. Seeking CagriSema from unregulated online sources carries significant health risks, including counterfeit products, incorrect dosages, and lack of medical oversight, which can be dangerous.
Proven weight-loss medications available online today
While CagriSema is still in development, several highly effective and EMA-approved weight-loss medications are available through an online consultation with an EU-licensed doctor.
- Ozempic (semaglutide): An injectable GLP-1 receptor agonist, Ozempic helps regulate blood sugar and reduce appetite, suitable for individuals with type 2 diabetes and often prescribed off-label for weight management where appropriate.
- Wegovy (semaglutide): A higher-dose formulation of semaglutide, Wegovy is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
- Mounjaro (tirzepatide): This innovative medication is a dual GIP and GLP-1 receptor agonist, offering significant weight loss and blood sugar control, approved for type 2 diabetes and increasingly used for weight management under medical supervision.
- Saxenda (liraglutide): Another GLP-1 receptor agonist, Saxenda is an injectable medication approved for chronic weight management, working by increasing feelings of fullness and reducing hunger.
How to get a weight-loss prescription online in Lithuania
Hi-Doctor makes accessing approved weight-loss treatments straightforward and safe for patients in Lithuania. Here’s how our 4-step process works:
- Complete a short online questionnaire: Spend 2-3 minutes providing essential medical information.
- EU-licensed doctor reviews your case: An experienced Hi-Doctor physician, licensed in the EU, will thoroughly assess your medical history and suitability for treatment.
- REMPE prescription in <24 h if appropriate: If the doctor determines a treatment is safe and suitable, you'll receive a downloadable PDF REMPE electronic prescription (Spanish standard, valid EU-wide) within 24 hours to your private account and email. If treatment is not appropriate, your €25 consultation fee is automatically refunded.
- Pick up at any EU pharmacy: Present your digital or printed prescription at any pharmacy in Lithuania or across the EU, thanks to cross-border prescription directive 2011/24/EU.
The entire online consultation costs a flat rate of €25, with a money-back guarantee if treatment is not prescribed.
Why choose Hi-Doctor over unregulated peptide sellers
Choosing a regulated platform like Hi-Doctor ensures your safety, privacy, and access to genuine medications. Unlike unregulated peptide sellers or 'research chemical' vendors, Hi-Doctor provides:
- EU-licensed doctors: All consultations are conducted by medical professionals authorized to practice within the EU.
- Real medications: Prescriptions are for EMA-approved drugs, sourced from legitimate pharmacies.
- Traceability and regulation: Every step, from consultation to prescription, adheres to strict EU medical and data protection (RGPD) standards.
- Auditable patient records: All interactions are securely stored within your private, RGPD-compliant account.
- Proven track record: With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor is a trusted name in online healthcare.
Your health is paramount. Avoid the risks associated with grey-market peptides and choose the safety and expertise offered by Hi-Doctor.
COMMON QUESTIONS
Frequently asked questions
No, CagriSema is not legally available for purchase or prescription in Lithuania or any EU country. It is still an investigational drug without EMA approval.
